Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV - Kenya, 1998-2012

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yuen, Courtney M ^a   Weyenga, Herman O ^b   Kim, Andrea A ^c   Malika, Timothy ^b   Muttai, Hellen ^c   Katana, Abraham ^c   Nganga, Lucy ^c   Cain, Kevin P ^c   De Cock, Kevin M ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINISTRY OF HEALTH   (Kenya)

^c Centers for Disease Control and Prevention Kenya   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; COMPARATIVE STUDY; CONCURRENT INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG UPTAKE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; KENYA; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION RESEARCH; PREVALENCE; RISK REDUCTION; SENSITIVITY ANALYSIS; TREND STUDY; TUBERCULOSIS; COINFECTION; COMPLICATION; HIV INFECTIONS; MIDDLE AGED; TUBERCULOSIS, PULMONARY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; COINFECTION; HIV INFECTIONS; HUMANS; INCIDENCE; KENYA; MIDDLE AGED; PREVALENCE; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84903287091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099880     Document Type: Article

References (30)

1. World Health Organization (2013) Global tuberculosis report 2013. Geneva: World Health Organization.
2. Kwan CK, Ernst JD (2011) HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 24: 351-376.
3. Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, et al. (2011) Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health 11: 696.
4. van't Hoog AH, Williamson J, Sewe M, Mboya P, Odeny LO, et al. (2012) Risk factors for excess mortality and death in adults with tuberculosis in Western Kenya. Int J Tuberc Lung Dis 16: 1649-1656.
5. Harries AD, Lawn SD, Getahun H, Zachariah R, Havlir DV (2012) HIV and tuberculosis-science and implementation to turn the tide and reduce deaths. J Int AIDS Soc 15: 17396.
6. Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, et al. (2012) Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med 9: e1001270.
7. Akolo C, Adetifa I, Shepperd S, Volmink J (2010) Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev: CD000171.
8. Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, et al. (2011) 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 377: 1588-1598.
9. Chakaya JM, Mansoer JR, Scano F, Wambua N, L'Herminez R, et al. (2008) National scale-up of HIV testing and provision of HIV care to tuberculosis patients in Kenya. Int J Tuberc Lung Dis 12: 424-429. (Pubitemid 351507256)
10. National AIDS and STI Control Programme, Ministry of Health, Kenya (2012) Kenya AIDS Epidemic Update 2011. Nairobi, Kenya.
11. Richards SB, St Louis ME, Nieburg P, Coulibaly IM, Coulibaly D, et al. (1995) Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Cote d'Ivoire. Tuber Lung Dis 76: 11-16.
12. National AIDS and STI Control Programme, Ministry of Health, Kenya (2009) Kenya AIDS Indicator Survey: Final Report. Nairobi, Kenya.
13. National AIDS and STI Control Programme, Ministry of Health, Kenya (2013) Kenya AIDS Indicator Survey 2012: Preliminary report. Nairobi, Kenya.
14. Division of Leprosy, Tuberculosis and Lung Disease, Ministry of Health, Kenya (2012) Annual Report 2011. Nairobi, Kenya.
15. UNAIDS Spectrum/EPP website. Available: http://www.unaids.org/en/ dataanalysis/datatools/spectrumepp2013/. Accessed May 25, 2014.
16. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021. (Pubitemid 36548927)
17. Dye C, Glaziou P, Floyd K, Raviglione M (2013) Prospects for tuberculosis elimination. Annu Rev Public Health 34: 271-286.
18. Centers for Disease Control and Prevention (2012) CDC Grand Rounds: the TB/HIV syndemic. MMWR Morb Mortal Wkly Rep 61: 484-489.
19. Middelkoop K, Bekker LG, Myer L, Johnson LF, Kloos M, et al. (2011) Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 56: 263-269.
20. Obermeyer CM, Bott S, Bayer R, Desclaux A, Baggaley R, et al. (2013) HIV testing and care in Burkina Faso, Kenya, Malawi and Uganda: ethics on the ground. BMC Int Health Hum Rights 13: 6.
21. Williams BG, Granich R, De Cock KM, Glaziou P, Sharma A, et al. (2010) Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci U S A 107: 19485-19489.
22. Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, et al. (2014) The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS 28 Suppl 1: S25-34.
23. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R (2009) Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 23: 1717-1725.
24. Van Rie A, Westreich D, Sanne I (2011) Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr 56: 349-355.
25. Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD (2012) Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One 7: e34156.
26. World Health Organization (2011) Guidelines for intensified tuberculosis case finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva: World Health Organization.
27. Corbett EL, Marston B, Churchyard GJ, De Cock KM (2006) Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367: 926-937.
28. Nardell E, Dharmadhikari A (2010) Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis 14: 1233-1243.
29. Chakaya J, Uplekar M, Mansoer J, Kutwa A, Karanja G, et al. (2008) Public-private mix for control of tuberculosis and TB-HIV in Nairobi, Kenya: outcomes, opportunities and obstacles. Int J Tuberc Lung Dis 12: 1274-1278.
30. Division of Leprosy, Tuberculosis and Lung Disease, Ministry of Health, Kenya (2013) Annual Report 2012. Nairobi, Kenya.